SELLAS Life Sciences Group Dividend
Dividend criteria checks 0/6
SELLAS Life Sciences Group does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.65 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely
Jul 13SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely
Sep 20SELLAS Life Sciences rises 9% after cancer drug shows promising result in animal study
Aug 09We Think SELLAS Life Sciences Group (NASDAQ:SLS) Needs To Drive Business Growth Carefully
Mar 08Is SELLAS Life Sciences Group (NASDAQ:SLS) In A Good Position To Invest In Growth?
Nov 23Companies Like SELLAS Life Sciences Group (NASDAQ:SLS) Are In A Position To Invest In Growth
Jul 19SELLAS Life Sciences updates on at-the-market offering
Jun 02SELLAS Life Sciences jumps 43% after Reddit mentions
Feb 03Sellas' galinpepimut-S combo shows promising action in early-stage solid tumor studies
Dec 21Sellas Life Sciences strengthens balance sheet with addition of $30.5M
Dec 17Sellas Life Sciences prices $16.2M direct offering
Dec 14Nelipepimut-S data from breast cancer study fails to lift SELLAS Life Sciences
Dec 11SELLAS and 3D Medicines in exclusive license agreement for development and commercialization of GPS and GPS+ in Greater China
Dec 07SELLAS Life Sciences EPS misses by $0.26
Nov 13Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SLS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SLS's dividend payments have been increasing.
Dividend Yield vs Market
SELLAS Life Sciences Group Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (SLS) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (SLS) | n/a |
Notable Dividend: Unable to evaluate SLS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SLS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SLS's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SLS has not reported any payouts.